Tumor microenvironment and lymphocyte infiltration Gwendoline RahirMuriel Moser Review 10 April 2012 Pages: 751 - 759
Reflections upon human cancer immune responsiveness to T cell-based therapy Ena WangSara TomeiFrancesco M. Marincola Opinion Paper Open access 11 May 2012 Pages: 761 - 770
Increased lymphocyte infiltration in patients with head and neck cancer treated with the IRX-2 immunotherapy regimen Neil L. BerinsteinGregory T. WolfJohn W. Hadden Original article 06 November 2011 Pages: 771 - 782
A short course of neoadjuvant IRX-2 induces changes in peripheral blood lymphocyte subsets of patients with head and neck squamous cell carcinoma Theresa L. WhitesideLisa H. ButterfieldNeil L. Berinstein Original article 23 November 2011 Pages: 783 - 788
Expression of antigen processing and presenting molecules in brain metastasis of breast cancer Yan LiuYoshihiro KomoharaHideho Okada Original article 08 November 2011 Pages: 789 - 801
Genome-wide differential genetic profiling characterizes colorectal cancers with genetic instability and specific routes to HLA class I loss and immune escape Mónica BernalFernando García-AlcaldeFrancisco Ruiz-Cabello Original Article 10 November 2011 Pages: 803 - 816
Enhanced cytotoxicity and decreased CD8 dependence of human cancer-specific cytotoxic T lymphocytes after vaccination with low peptide dose Tanja LövgrenPetra BaumgaertnerDaniel E. Speiser Original article 12 November 2011 Pages: 817 - 826
Myeloid-derived suppressor cells impair the quality of dendritic cell vaccines I. PoschkeY. MaoR. Kiessling Original article 12 November 2011 Pages: 827 - 838
Immunotherapy with IL-10- and IFN-γ-producing CD4 effector cells modulate “Natural” and “Inducible” CD4 TReg cell subpopulation levels: observations in four cases of patients with ovarian cancer Mark J. DobrzanskiKathleen A. Rewers-FelkinsStephen E. Wright Original article 15 November 2011 Pages: 839 - 854
Calreticulin as a potential diagnostic biomarker for lung cancer Rongrong LiuJiuyu GongBoquan Jin Original Article 15 November 2011 Pages: 855 - 864
Vaccination with dendritic cells loaded with tumor apoptotic bodies (Apo-DC) in patients with chronic lymphocytic leukemia: effects of various adjuvants and definition of immune response criteria Marzia PalmaLotta HanssonAnders Österborg Original article 16 November 2011 Pages: 865 - 879
Remodeling of the epitope repertoire of a candidate idiotype vaccine by targeting to lysosomal degradation in dendritic cells Debora MartorelliGiuseppe CoppotelliMaria G. Masucci Original article 17 November 2011 Pages: 881 - 892
CAF05: cationic liposomes that incorporate synthetic cord factor and poly(I:C) induce CTL immunity and reduce tumor burden in mice Jon HansenThomas LindenstrømElse Marie Agger Original Article 18 November 2011 Pages: 893 - 903
The additional value of TGFβ1 and IL-7 to predict the course of prostate cancer progression Caroline SchrotenNatasja F. DitsRobert Kraaij Original article Open access 24 November 2011 Pages: 905 - 910
Regulatory T cells increase in breast cancer and in stage IV breast cancer Zhi-kuan WangBo YangShun-chang Jiao Original article 25 November 2011 Pages: 911 - 916
Enhancement of tumor immunotherapy by deletion of the A2A adenosine receptor Adam T. WaickmanAngela AlmeJonathan D. Powell Original article 25 November 2011 Pages: 917 - 926
Characterization of the evolution of immune phenotype during the development and progression of squamous cell carcinoma of the head and neck Anna-Maria A. De CostaCorinne A. SchuylerM. Rita I. Young Original Article 25 November 2011 Pages: 927 - 939
Intact interferon signaling in peripheral blood leukocytes of high-grade osteosarcoma patients Emilie P. BuddinghS. Eriaty N. RuslanArjan C. Lankester Short communication Open access 10 March 2012 Pages: 941 - 947
Highlights of novel melanoma therapies presented at the 8th International Congress of the Society for Melanoma Research (SMR) Tampa, FL, November 9–11, 2011 Dorothee Herlyn Meeting report 07 March 2012 Pages: 949 - 951
